Dr. Yang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
160 E. 34th Street
New York, NY 10016
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2012 - 2016
Yale School of MedicineClass of 2011
Certifications & Licensure
NJ State Medical License 2017 - 2025
NY State Medical License 2012 - 2025
WA State Medical License 2022 - 2025- American Board of Radiology Radiation Oncology
Clinical Trials
- Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain Start of enrollment: 2018 May 01
- Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease Start of enrollment: 2019 Jan 16
Roles: Contact, Principal Investigator
- Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors Start of enrollment: 2020 Apr 10
Publications & Presentations
PubMed
- 169 citationsA phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases.Cameron Brennan, T. Jonathan Yang, Patrick Hilden, Zhigang Zhang, Kelvin Chan
International Journal of Radiation Oncology, Biology, Physics. 2014-01-01 - 39 citationsClinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapyT. Jonathan Yang, Jung Hun Oh, Aditya Apte, Christina H. Son, Joseph O. Deasy
Radiotherapy and Oncology. 2014-10-01 - 464 citationsEstimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)Paul W. Sperduto, T. Jonathan Yang, Kathryn Beal, Hubert Y. Pan, Paul D. Brown
JAMA Oncology. 2017-06-01
Journal Articles
- Marked Response of a Hypermutated Adrenocorticotropic Hormone-Secreting Pituitary Carcinoma to Ipilimumab and NivolumabMichael Postow, Viviane Tabar, T Jonathan Yang, John Cuaron, Jinru Shia, Lisa M DeAngelis, The Journal of Clinical Endocrinology and Metabolism
Press Mentions
Proton CSI: New Standard of Care for Leptomeningeal Metastases?October 14th, 2024- ‘Brutal’ Plan to Restrict Palliative Radiation During PandemicApril 6th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
